跳至主要内容
临床试验/NCT02437448
NCT02437448已完成不适用

Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS) in Patients With Pulmonary Fibrosis

University of Zurich1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
1
主要终点
IPF-specific mass spectrometric profile of volatile organic compounds of exhaled breath analysis (markers of IPF in exhaled breath)

研究概览

简要总结

The aim of the study is to answer the question whether a disease specific profile of breath in patients with idiopathic lung fibrosis can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical symptoms consistent with IPF
  • Age 40 through 80 years
  • Diagnosis of UIP or IPF by HRCT and surgical lung biopsy as outlined in table
  • Only patients fulfilling the category "YES" will be included in the study.
  • Extent of fibrotic changes (honeycombing, reticular changes) greater than extent of emphysema on HRCT scan
  • No features supporting an alternative diagnosis

排除标准

  • Acute exacerbation within the last 6 weeks.
  • Any relevant lung disease other than pulmonary fibrosis.
  • Acute inflammatory disease (e.g. common cold) within the last 6 weeks.
  • Acute or chronic hepatic disease.
  • Renal failure or renal replacement therapy.

结局指标

主要结局

IPF-specific mass spectrometric profile of volatile organic compounds of exhaled breath analysis (markers of IPF in exhaled breath)

时间窗: 1 day

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Malcolm Kohler

Prof

University of Zurich

研究点 (1)

Loading locations...

相似试验

Breath Analysis in Lung Fibrosis | 临床试验